Form 4 for ANGO ANGIODYNAMICS INC
Accepted 2023-07-18 00:00:00 ET · period of report 2023-07-14 · accession 0001140361-23-035087 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-07-18 | 2023-07-14+ | ANGO | Trowbridge Stephen A | EVP, CFO | F - Tax | $9.61 | -1,738 | 87.7K | -2% | -$16.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-07-17 | F | D | 376 | $9.56 | 87,288 | D | — | — | (F2) The exempt disposition of 376 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 17, 2019. |
| 2 | Common | Common Stock | 2023-07-14 | F | D | 1,362 | $9.63 | 87,664 | D | — | — | (F1) The exempt disposition of 1,362 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 14, 2020. |